Cairo – The Egyptian Exchange’s (EGX) listing committee approved the request of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) to increase its issued capital to EGP 192.15 million from EGP 160.9 million.
The company’s capital will be raised by EGP 31.25 million, distributed over 125 million shares, at a nominal value of EGP 0.25 apiece, in addition to issuance bonus of EGP 4.41, the EGX said in a statement on Thursday.
The capital increase shares will be listed as of the beginning of trading session on 9 December.
It is worth mentioning that during the first nine months of 2019, Rameda logged a consolidated profit of EGP 31.14 million, compared to EGP 76.64 million in the corresponding period of 2018, including minority shareholders’ rights.
All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).